Voyager Therapeutics Cash Flow - Annual (NASDAQ:VYGR)

Add to My Stocks
$18.02 $0.37 (2.01%) VYGR stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Voyager Therapeutics from an investment perspective, its important to check the cash flow statement. While its important to look at the Voyager Therapeutics debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Voyager Therapeutics revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in Voyager Therapeutics stock analysis. Voyager Therapeutics had a negative net income cash flow of $-70.69M for the latest 2017. This report is very useful in measuring the short term viability of a company. Voyager Therapeutics has a negative cash and cash equivalents change of $-5.11M.

View details of Voyager Therapeutics cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.57M1.3M1.05M--
Net Increase (Decrease) in Assets Liabilities-1.62M-11.79M56.41M1.24M1.04M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net9.39M8.2M13.5M2.96M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-3.98M-5.02M-1.03M-2.98M-
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-52.75M-193.73M--
Other Cash Inflow (Outflow) from Investment Activities--0.42M--0.31M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares59.92M-177.74M22.12M-
Issuance (Repayment) of Debt Securities-----
Increase (Decrease) in Bank & Other Borrowings----2.86M
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-----
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year36.64M31.3M7.03M--
Cash & Equivalents at Year End31.53M36.64M31.3M7.03M-
All figures in USD. M: Millions of USD, B: Billions of USD.

Voyager Therapeutics stock comparison chart provides an easy way to compare the stock price with peers along with details of Voyager Therapeutics stock price history.
The statement of cash flows can be categorized into three main sections:

  • Voyager Therapeutics had a Net Change in Cash and Cash Equivalents of $-5.11M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Voyager Therapeutics stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • The cash generated from the core business or operations was a negative at $-61.35M for Voyager Therapeutics in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-3.68M for VYGR stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $59.92M for Voyager Therapeutics. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Voyager Therapeutics Cash Flow

Annual Cash Flow Statements For Voyager Therapeutics Inc Peers

Biogen Inc cash flow, Cymabay cash flow, Ionis Pharma cash flow, PTC Therapeutics cash flow, Skyepharma cash flow